Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa

被引:7
|
作者
Kussmann, Manuel [1 ]
Hauer, Stefan [1 ]
Pichler, Petra [2 ]
Reznicek, Gottfried [3 ]
Burgmann, Heinz [1 ]
Poeppl, Wolfgang [1 ,4 ]
Zeitlinger, Markus [5 ]
Wiesholzer, Martin [2 ]
机构
[1] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Internal Med 1, Vienna, Austria
[2] Karl Landsteiner Univ Hlth Sci, Univ Hosp St Poelten, Dept Internal Med 1, St Polten, Austria
[3] Univ Vienna, Dept Pharmacognosy, Vienna, Austria
[4] Austrian Armed Forces, Mil Med Cluster East, Vienna, Austria
[5] Med Univ Vienna, Dept Clin Pharmacol, Waehringerguertel 18-20, A-1090 Vienna, Austria
关键词
Antibiotics; Infection; Peritoneal dialysis solutions; Peritonitis; Time-kill curves; INTRAVENOUS FOSFOMYCIN; ANTIBIOTICS; INTRAPERITONEAL; CIPROFLOXACIN; DAPTOMYCIN; ERTAPENEM; OUTCOMES; PH;
D O I
10.1007/s10096-018-3221-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Peritonitis is still the main infectious complication among patients on peritoneal dialysis. For treatment of peritoneal dialysis-related peritonitis, the intraperitoneal administration of antibiotics admixed to peritoneal dialysis fluids (PDFs) should be preferred. However, the influence of diverse PDFs on the activity of frequently used antibiotics has been investigated insufficiently. Thus, the present study set out to investigate the in vitro activity of fosfomycin against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus epidermidis, and Staphylococcus aureus in commercially available PDFs. Time-kill curves in four different PDFs (DianealA (R), ExtranealA (R), NutrinealA (R), and PhysionealA (R)) were performed over 24 h with two different concentrations of fosfomycin (150 and 400 mg/L) and without antibiotics as control. Cation-adjusted Mueller Hinton broth (CA-MHB) was used as a comparator solution. In blank PDFs, bacterial growth of each organism evaluated was reduced when compared to CA-MHB. For S. aureus in blank PhysionealA (R), a reduction under the limit of detection was observed within 24 h. The activity of fosfomycin was reduced in all PDFs when compared to CA-MHB except for P. aeruginosa in NutrinealA (R) where the activity of fosfomycin was increased when investigated at 400 mg/L. Against E.coli, bactericidal activity was demonstrated in ExtranealA (R), NutrinealA (R), and PhysionealA (R). Fosfomycin resistance (MIC > 1024 mg/L) was observed for P. aeruginosa in CA-MHB at both concentrations and in NutrinealA (R) at 150 mg/L. Fosfomycin is active in PDFs particularly against the frequently isolated enterobacterium E. coli. The choice of the respective PDF considerably influences the microbiological outcome in vitro. Further studies are warranted to investigate the clinical relevance of these findings.
引用
收藏
页码:1091 / 1098
页数:8
相关论文
共 50 条
  • [41] Activity of lipo-cyclic γ-AApeptides against biofilms of Staphylococcus epidermidis and Pseudomonas aeruginosa
    Padhee, Shruti
    Li, Yaqiong
    Cai, Jianfeng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (12) : 2565 - 2569
  • [42] Biofilm-Forming Capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from Ocular Infections
    Hou, Wenbo
    Sun, Xuguang
    Wang, Zhiqun
    Zhang, Yang
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (09) : 5624 - 5631
  • [43] SYNERGISM OF FLEROXACIN AND FOSFOMYCIN AGAINST PSEUDOMONAS-AERUGINOSA AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    HIRAI, K
    HOSAKA, M
    NIWATA, Y
    NISHINO, K
    REVIEWS OF INFECTIOUS DISEASES, 1989, 11 : S1044 - S1044
  • [44] Antibiofilm Activity of Small Molecules Produced by Staphylococcus epidermidis against Staphylococcus aureus
    Kumari, Anjna
    Singh, Rachna
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2020, 86 (13)
  • [45] Interspecies Interaction between Pseudomonas aeruginosa, Staphylococcus aureus and E. coli in vitro
    Abdelwahab, Ibrahim A.
    Abozahra, Rania R.
    Sultan, Shawky A.
    Abd-elaal, Hala M.
    Abdelhamid, Sarah M.
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2023, 17 (01): : 467 - 485
  • [46] In vitro and in vivo anti-biofilm activity of pyran derivative against Staphylococcus aureus and Pseudomonas aeruginosa
    Su, Shan
    Yin, Pengshuo
    Li, Jing
    Chen, Guanghui
    Wang, Yikun
    Qu, Di
    Li, Zhoupeng
    Xue, Xiaoyan
    Luo, Xiaoxing
    Li, Mingkai
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (05) : 791 - 799
  • [47] The evaluation of antimicrobial activity of zinc oxide nanoparticles on Candida albicans, Pseudomonas aeruginosa, Escherichia coli and Staphylococcus aureus
    Haghighi, F.
    Mohammadi, S. Roudbar
    Eskandari, M.
    Sadaat, M.
    MYCOSES, 2011, 54 : 62 - 62
  • [48] Characterization, cell toxicity, and antimicrobial activity of a carvacrol-encapsulating nanoliposomal system against Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli
    Yazdi, Ali Majidi
    Hosseini, Arshad
    Gheibihayat, Seyed Mohammad
    Beygi, Mohammad
    Haghiralsadat, Bibi Fatemeh
    Oroojalian, Fatemeh
    NANOMEDICINE JOURNAL, 2024, 11 (01) : 93 - 106
  • [49] ANTIBACTERIAL ACTIVITY OF SUCRALFATE AGAINST ESCHERICHIA-COLI, STAPHYLOCOCCUS-AUREUS AND PSEUDOMONAS-AERUGINOSA IN BATCH AND CONTINUOUS-CULTURE
    WEST, AP
    ABDUL, S
    SHERRATT, MJ
    INGLIS, TJJ
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (11) : 869 - 871
  • [50] Synergistic effect of artocarpin on antibacterial activity of some antibiotics against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli
    Septama, Abdi Wira
    Panichayupakaranant, Pharkphoom
    PHARMACEUTICAL BIOLOGY, 2016, 54 (04) : 686 - 691